Abstract
Background: Biological agents are the mainstay of treatment for moderate-to-severe psoriasis. However, some patients treated with biologics demonstrate poor clinical responses, possibly due to formation of antidrug antibodies (ADAs). We conducted a review of literature to evaluate whether the cellular lineage of the biological agent impacts ADA formation and treatment efficacy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
